YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Johnson & Johnson enters late-stage trial testing for vaccine

Posted online

Johnson & Johnson announced today it started Phase III trial testing on a potential COVID-19 vaccine.

The company becomes the fourth backed by the Trump administration's Operation Warp Speed vaccine program to reach late-stage testing. Moderna, Pfizer and AstraZeneca are the other companies.

J&J plans to enroll up to 60,000 adult volunteers for the trial.

Read more from CNBC.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Fall 2026 Architects & Engineers Project Report

This installment of Springfield Business Journal’s Architects & Engineers Project Report showcases 26 endeavors by area design and engineering professionals.

Most Read
Update cookies preferences